On Tuesday, Novavax announced that it was moving forward with its clinical trials for its coronavirus vaccine. This comes as a Merck announced it would begin to develop its own vaccine with IAVI and that the company would purchase Austrian vaccine maker Themis Bioscience. Yahoo Finance’s Anjalee Khemlani joins The Final Round to break down the latest news about the coronavirus. …read more
Source:: Yahoo Finance
